Terms: = Head and neck cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Clinical Outcome
4 results:
1. MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma.
Yamauchi T; Fujishima F; Tsunokake J; Kunimitsu A; Akaishi R; Ozawa Y; Fukutomi T; Okamoto H; Sato C; Taniyama Y; Kamei T; Ichinohasama R; Sasano H
Int J Biol Markers; 2023 Jun; 38(2):105-113. PubMed ID: 37009661
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas.
Wong KS; Lorch JH; Alexander EK; Nehs MA; Nowak JA; Hornick JL; Barletta JA
Thyroid; 2019 May; 29(5):666-673. PubMed ID: 30869569
[No Abstract] [Full Text] [Related]
3. [Sebaceous tumors of the eyelids in a patient with Muir-Torre syndrome].
Bertholom JL; Guyomard JL; Stock N; Dugast C; Martinel C; Chatel MA; Charlin JF
J Fr Ophtalmol; 2006 Jun; 29(6):654-8. PubMed ID: 16885896
[TBL] [Abstract] [Full Text] [Related]
4. Deficiency of hMLH1 and hmsh2 expression is a poor prognostic factor in esophageal squamous cell carcinoma.
Uehara H; Miyamoto M; Kato K; Cho Y; Kurokawa T; Murakami S; Fukunaga A; Ebihara Y; Kaneko H; Hashimoto H; Murakami Y; Shichinohe T; Kawarada Y; Itoh T; Okushiba S; Kondo S; Katoh H
J Surg Oncol; 2005 Nov; 92(2):109-15. PubMed ID: 16231369
[TBL] [Abstract] [Full Text] [Related]
